• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • News
  • Topics
    • Common Sense
    • Congress
    • Debt
    • Government waste
    • Millenials
    • QuizCap
    • Taxes
  • Tools
    • Agencies
    • Memes That Matter
    • Research Library
    • Scavenger Hunt
  • Shop
  • What We’re About
  • Multimedia
  • What We’re About
  • Contact Us
  • Newsletter signup
  • Give to the Cause

GAO: Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals

April 1, 2016

Pursuit's Take

Certain providers, including hospitals that serve a disproportionate number of low-income patients, have access to discounted prices on outpatient drugs through the 340B Drug Pricing Program. GAO found that in both 2008 and 2012, per beneficiary Medicare Part B drug spending, including oncology drug spending, was substantially higher at 340B DSH hospitals than at non-340B hospitals. This indicates that, on average, beneficiaries at 340B DSH hospitals were either prescribed more drugs or more expensive drugs than beneficiaries at the other hospitals in GAO’s analysis.

Media Coverage

AJMC: GAO Report: Congress Must End Incentives to Prescribe Expensive Cancer Drugs in 340B Program

Town Hall: Exploiting the Poor: Hospitals and Chain Drug Stores

Read the full report Artboard 1

sidebar

sidebar-alt

Support Our Work

Federal agencies go largely unchecked, spending at will making use of inflated budgets. While some do very important work, we need to hold them accountable. You can do this by donating, emailing your legislator, or signing our petitions.

Donate Now

Sign Up for Pursuit Updates

Privacy Policy

Powered by the Foundation to Restore Accountability

Search
UNCOVER SOME GOVERNMENT WASTE?
share your opinion

Can you believe the US Government spends more money on it’s cable bill than on disaster relief?

NO! I’M FURIOUS! Eh, sounds right